January 17, 2024 06:58 AM EST
People
Manufacturing

Reagent mak­er Al­pha Tekno­va cuts 15% of work­ers, ter­mi­nates com­mer­cial, peo­ple ex­ec roles amid down­turn

Anna Brown

News Reporter

Reagent man­u­fac­tur­er Al­pha Tekno­va is trim­ming 15% of its work­ers to save around $6.4 mil­lion, ac­cord­ing to a Tues­day SEC fil­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times